Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
J Appl Microbiol. 2012 Apr;112(4):683-94. doi: 10.1111/j.1365-2672.2012.05251.x. Epub 2012 Feb 29.
S-adenosyl-l-methionine (SAM) is an important biochemical molecule with great potential in the pharmacological and chemotherapeutic fields. In this study, our aims were to enhance SAM production in Saccharomyces cerevisiae.
Through spaceflight culture, a SAM-accumulating strain, S. cerevisiae H5M147, was isolated and found to produce 86·89% more SAM than its ground control strain H5. Amplified fragment length polymorphism (AFLP) analysis demonstrated that there were genetic variations between strain H5M147 and its ground control. Through recombinant DNA technology, the heterologous gene encoding methionine adenosyltransferase was integrated into the genome of strain H5M147. The recombinant strain H5MR83 was selected because its SAM production was increased by 42·98% when compared to strain H5M147. Furthermore, cultivation conditions were optimized using the one-factor-at-a-time and Taguchi methods. Under optimal conditions, strain H5MR83 yielded 7·76 g l(-1) of SAM in shake flask, an increase of 536·07% when compared to the strain H5. Furthermore, 9·64 g l(-1) of SAM was produced in fermenter cultivation.
A new SAM-accumulating strain, S. cerevisiae H5MR83, was obtained through spaceflight culture and genetic modification. Under optimal conditions, SAM production was increased to a relative high level in our study.
Through comprehensive application of multiple methods including spaceflight culture, genetic modification and optimizing cultivation, the yield of SAM could be increased by 6·4 times compared to that in the control strain H5. The obtained S. cerevisiae H5MR83 produced 7·76 g l(-1) of SAM in the flask cultures, a significant improvement on previously reported results. The SAM production period with S. cerevisiae H5MR83 was 84 h, which is shorter than previously reported results. Saccharomyces cerevisiae H5MR83 has considerable potential for use in industrial applications.
S-腺苷-L-蛋氨酸(SAM)是一种具有巨大药理学和化学治疗学潜力的重要生化分子。本研究旨在提高酿酒酵母中 SAM 的产量。
通过太空飞行培养,分离出一株 SAM 积累菌株酿酒酵母 H5M147,其 SAM 产量比地面对照菌株 H5 高出 86.89%。扩增片段长度多态性(AFLP)分析表明,菌株 H5M147 与其地面对照之间存在遗传变异。通过重组 DNA 技术,将编码蛋氨酸腺苷转移酶的异源基因整合到 H5M147 的基因组中。选择重组菌株 H5MR83,因为与 H5M147 相比,其 SAM 产量增加了 42.98%。此外,通过单因素试验和 Taguchi 方法优化了培养条件。在最佳条件下,菌株 H5MR83 在摇瓶中产生 7.76 g/L 的 SAM,与菌株 H5 相比增加了 536.07%。此外,在发酵罐培养中产生了 9.64 g/L 的 SAM。
通过太空飞行培养和遗传修饰获得了一株新的 SAM 积累菌株酿酒酵母 H5MR83。在最佳条件下,SAM 的产量相对较高。
通过综合应用包括太空飞行培养、遗传修饰和优化培养在内的多种方法,SAM 的产量与对照菌株 H5 相比增加了 6.4 倍。获得的酿酒酵母 H5MR83 在摇瓶培养中产生 7.76 g/L 的 SAM,显著高于之前的报道结果。与之前的报道结果相比,酿酒酵母 H5MR83 的 SAM 生产周期为 84 h,更短。酿酒酵母 H5MR83 具有很大的工业应用潜力。